Johnson & Johnson buys San Diego's Ambrx Biopharma for $2B

Johnson & Johnson agreed to acquire Ambrx Biopharma, which is developing cancer treatments. The biotech was spun out from The Scripps Research Institute in 2003.

Related Keywords

San Diego ,California ,United States ,La Jolla ,Danielj Oconnor ,Ambrx Biopharma ,Pfizer ,Johnson ,Scripps Research Institute ,San Diego Based Ambrx Biopharma ,Innovative Medicine ,North Torrey Pines Road ,Nasdaq Global Select ,